Avant Mutual Board

  • The Avant Mutual Group Limited Board has six member directors and (as required by the Constitution) three non member directors who are also representatives from the Insurance Board. As your MDO, the responsibilities of the Mutual Board relate to providing overall guidance and control of the organisation and a focus on the needs of members. Each year, two of the six member directors retire by rotation providing two vacancies on the Board.  Retiring directors are eligible to stand for re-election.  The directors on the Mutual Board are:

  • Dr Beverley Rowbotham (Chair)

    Associate Professor Beverley Rowbotham
    MBBS (Hons 1) MD, FRACP, FRCPA, FAICD

    Associate Professor Rowbotham is the Chair of AMGL and AGHL and is a Director of AIL, DHF and the Avant Foundation. She is Director of Haematology and a member of the Executive Advisory Committee at Sullivan Nicolaides Pathology. She is the Chair of the AMA Federal Council, the National Pathology Accreditation Advisory Committee and is a past President of the Royal College of Pathologists of Australasia. Dr Rowbotham is an Associate Professor at the University of Queensland, and is a member of the MBS Review Taskforce and other government committees. Dr Rowbotham is a fellow of the Australian Institute of Company Directors. She is a Director of RCPA Quality Assurance Programs Pty Limited, AEIOU Foundation for children with autism and Genome One.

    Special responsibilities: Director of Avant Foundation Limited and The Doctors’ Health Fund Pty Ltd. Member of the Remuneration Committee and Nominations Committee.

  • Mr Peter Beck

    Mr Peter Beck 
    BSc, FIA, FIAA, FSA, FASFA

    Mr Beck is a Director of AMGL, AGHL and AIL. Mr Beck is an actuary by profession and has over 30 years’ experience in banking, insurance, superannuation and investments working in Australia, New Zealand, Asia, South Africa and the United Kingdom. He was formerly CEO of Pillar Administration, CEO of CommInsure, and Group General Manager, Strategic Development and Group Appointed Actuary at Colonial.

    Special responsibilities: Chair of the Risk Committee, Chair of the Audit Committee and member of the Group Investment Committee.

  • Mr Tony Bofinger

    Mr Tony Bofinger
    BEc, MBA, FIAA, GAICD

    Mr Bofinger is a Director of AGHL and AIL. Mr Bofinger is an actuary with over 30 years’ experience in life insurance, superannuation and investment, and he has expertise in risk management, capital management and finance. He is currently Chief Risk Officer of Challenger Limited, and was previously Appointed Actuary and Chief Financial Officer of Challenger Life Company Limited. Prior to that he held a range of executive positions in direct insurance, reinsurance and consulting.

    Special responsibilities: Member of the Audit Committee and the Risk Committee.

  • Dr Jan Dudley

    Dr Jan Dudley
    MBBS, FRANZCOG, GAICD

    Dr Dudley is a Director of AMGL and AGHL. She is a VMO Obstetrician and Gynaecologist at both the Royal Hospital for Women in Randwick and Prince of Wales Private Hospital in Randwick, where she is Chairman of Obstetrics. Dr Dudley has significant governance experience at local hospital level, and was formerly a long standing and highly respected member of Avant’s Medical Experts Committee. Dr Dudley is a graduate of the Australian Institute of Company Directors.    

    Special responsibilities: Member of the Group Investment Committee.

  • The Hon John Fahey AC

    The Hon John Fahey AC

    The Hon John Fahey is a Director of AMGL, AGHL and AIL, and is the Chair of DHF. He was the Premier of NSW for three years, and then Federal Minister for Finance and Administration (1996-2001). Prior to Parliament, he practised as a solicitor. In 2002 he was awarded a Companion in the Order of Australia. He was appointed President of the World Anti-Doping Authority in 2007, a position he held until the end of 2013. In 2014, he was appointed as Chancellor of the Australian Catholic University. He is the current Chair of the Sydney Olympic Park Authority.

    Special responsibilities: Chair of The Doctors’ Health Fund Pty Ltd. Member of the Group Investment Committee and the Remuneration Committee.

  • Dr William Glasson

    Dr William Glasson 

    MBBS (Qld), FRANZCO, FRACS, FRACGP, FRCOphth, DipAppSc(Opt), GAICD 

    Dr William Glasson is a Director of AMGL and AGHL. Dr Glasson is a practising ophthalmologist working in urban, rural and regional Australia as well as in East Timor.

    Dr Glasson is the former Federal President of the Australian Medical Association and was awarded the Gold Medal for his services in 2017. He has been awarded an Order of Australia for his services to rural and regional medicine. Dr Glasson has significant skills and knowledge in finance, management and governance. He has served on a number of Boards, including the Medical and Allied Professional Superannuation Fund, Cancer Australia, St John Australia, Australian Medical Association, Royal Australia and NZ College of Ophthalmologists Board and QLD Urban Indigenous Health.

    Special responsibilities: Member of the Audit Committee and Risk Committee.

  • Dr Steve Hambleton

    Dr Steven Hambleton
    MBBS, FAMA, FRACGP (Hon), FAICD

    Dr Steve Hambleton is a Director of AMGL and AGHL. He is a former Federal President of the Australian Medical Association (AMA May 2011 to May 2014) and was awarded the Gold Medal for his services in 2015.
    Dr Hambleton is a current member of the Implementation Advisory Group for the Health Care Home and the Australian Commission on Safety and Quality in Health Care Atlas of Clinical Variation working group and is Co-Sponsor Clinical Programs with the Australian Digital Health Agency. He is also Deputy Chair of the Medicare Benefits Schedule Review Taskforce.

    Special responsibilities: Member of Group Investment Committee.

  • Mr Peter Polson

    Mr Peter Polson
    BCom, MBL, PMD

    Mr Polson is a Director of AMGL and AGHL and is the Chair of AIL. He has an extensive background in banking, insurance and financial services. He was formerly Managing Director of Colonial First State Investments, and with the Commonwealth Bank Group as Group Executive responsible for all Investment and Insurance Services. Mr Polson is the current Chairman of the Board of Challenger Financial Services Group Limited, Challenger Life Limited, IDP Education Pty Limited and the Chairman of Very Special Kids.

    Special responsibilities: Chair of the Group Investment Committee, member of the Remuneration Committee and the Nominations Committee.

  • Dr Douglas Travis

    Dr Douglas Travis
    MBBS, FRACS, FAMA, GAICD

    Dr Doug Travis is a Director of AMGL and AGHL. He is a urological consultant practising in both the public and private health systems in Victoria. Dr Travis currently holds the position of Honorary Consultant at Melbourne’s Western Health in parallel with working as a urological consultant at his own practice in Melbourne’s Western suburbs. Dr Travis was recently appointed as the chair of Better Care Victoria, a Victorian State Government innovation for healthcare. In 2014 he was appointed by the new Victorian Government to head the Travis Review, a study to increase the capacity of the Victorian public hospital system for better patient outcomes. Dr Travis held the position of AMA Victoria State President 2007-2009 and was Chair of the Federal AMA Audit Committee until 2012. He is a former member of Avant’s Medical Experts Committee.

    Special responsibilities: Member of the Audit Committee and Risk Committee.

  • Professor Simon Willcock

    Professor Simon Willcock
    MBBS (Hons I), PhD, FRACGP, Dip. Obs. RANZCOG/RACGP, GAICD

    Professor Willcock is a Director of AMGL, AGHL, AIL and DHF. Previously Professor Willcock was the the Chair of AMGL and AGHL. He is a General Practitioner who has worked in both rural and urban NSW. Professor Willcock is currently the Director of Primary Care at Macquarie University Hospital, and his educational and research interests include musculoskeletal medicine, the health of doctors and generational change in the medical workforce. In 2013, Professor Willcock was inducted into the AMA’s Roll of Fellows, in recognition of his contribution to the medical profession. Professor Willcock is a graduate of the Australian Institute of Company Directors.

    Special responsibilities: Chair of the Nominations Committee and member of the Remuneration Committee.

  • Loyalty Reward Plan